[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Castelli et al., 2002 - Google Patents

HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity

Castelli et al., 2002

Document ID
17495436663270240043
Author
Castelli F
Buhot C
Sanson A
Zarour H
Pouvelle-Moratille S
Nonn C
Gahery-Ségard H
Guillet J
Ménez A
Georges B
Maillère B
Publication year
Publication venue
The Journal of Immunology

External Links

Snippet

Abstract Among HLA-DP specificities, HLA-DP4 specificity involves at least two molecules, HLA-DPA1* 0103/DPB1* 0401 (DP401) and HLA-DPA1* 0103/DPB1* 0402 (DP402), which differ from each other by only three residues. Together, they are present worldwide at an …
Continue reading at journals.aai.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus

Similar Documents

Publication Publication Date Title
Castelli et al. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity
Touloukian et al. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice
US20210188913A1 (en) Modified epitopes for boosting cd4+ t-cell responses
Livingston et al. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes
Southwood et al. Several common HLA-DR types share largely overlapping peptide binding repertoires
EP0656788B1 (en) Hla binding peptides and their uses
US5880103A (en) Immunomodulatory peptides
Kobayashi et al. Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen
US20080260762A1 (en) HLA binding motifs and peptides and their uses
Millrain et al. Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis
WO1994004171A9 (en) Immunomodulatory peptides
Romero et al. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule.
JP2016527875A (en) Improved method for detection, preparation and depletion of CD4 + T lymphocytes
JP2022513019A (en) Immunogenic peptide with a novel redox enzyme motif
US20160022787A1 (en) Peptide Immunogens
Sundaram et al. A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A∗ 0201 transgenic mice: implications for HTLV-1 vaccine design
Sette et al. Class I molecules with similar peptide-binding specificities are the result of both common ancestry and convergent evolution
Clayberger et al. Recognition of an HLA public determinant (Bw4) by human allogeneic cytotoxic T lymphocytes.
US6156316A (en) Oncogene fusion protein peptide vaccines
Itoh et al. Determination of amino acids on agretopes of pigeon cytochrome c‐related peptides specifically bound to I‐A allelic products
AU764550B2 (en) Isolated peptides which bind to HLA-B35 molecules
Wu et al. The Dermatophagoides pteronyssinus group 2 allergen contains a universally immunogenic T cell epitope
Depil et al. Peptide-binding assays and HLA II transgenic Aβ° mice are consistent and complementary tools for identifying HLA II-restricted peptides
Newman et al. T-lymphocyte epitope identification and their use in vaccine development for HIV-1
Busson et al. Prediction of CD4+ T cell epitopes restricted to HLA-DP4 molecules